These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35585907)

  • 21. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment.
    Gaur A; Gallagher D; Herrmann N; Chen JJ; Marzolini S; Oh P; Amemiya Y; Seth A; Kiss A; Lanctôt KL
    J Geriatr Psychiatry Neurol; 2025 Jan; 38(1):62-72. PubMed ID: 38757180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Neurofilament Light Chain Levels Are Associated With Cortical Hypometabolism in Alzheimer Disease Signature Regions.
    Mayeli M; Mirshahvalad SM; Aghamollaii V; Tafakhori A; Abdolalizadeh A; Rahmani F;
    J Neuropathol Exp Neurol; 2019 Aug; 78(8):709-716. PubMed ID: 31305887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
    Parbo P; Madsen LS; Ismail R; Zetterberg H; Blennow K; Eskildsen SF; Vorup-Jensen T; Brooks DJ
    Alzheimers Res Ther; 2020 Jan; 12(1):3. PubMed ID: 31898549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
    Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS
    Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma neurofilament light chain levels in Alzheimer's disease.
    Zhou W; Zhang J; Ye F; Xu G; Su H; Su Y; Zhang X;
    Neurosci Lett; 2017 May; 650():60-64. PubMed ID: 28428015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease.
    Huang X; Zhao J; Wang Q; Yan T; Gou S; Zhu X; Yang L; Ye F; Zhang J; Wang Y; Yang S; Le W; Xiang Y
    CNS Neurosci Ther; 2024 Feb; 30(2):e14606. PubMed ID: 38334009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI.
    Bangen KJ; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Solders S; Delano-Wood L; Galasko DR; Bondi MW;
    Alzheimers Dement; 2021 Oct; 17(10):1756-1762. PubMed ID: 33860596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neurofilament light chain level as a predictor of cognitive stage transition.
    Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
    Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals.
    Nabizadeh F; Ward RT; Balabandian M; Kankam SB; Pourhamzeh M
    Curr J Neurol; 2023 Oct; 22(4):221-230. PubMed ID: 38425361
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
    Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
    Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases.
    Liu S; Huang Z; Zhang L; Pan J; Lei Q; Meng Y; Li Z
    Front Aging Neurosci; 2020; 12():10. PubMed ID: 32082140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
    Sugarman MA; Zetterberg H; Blennow K; Tripodis Y; McKee AC; Stein TD; Martin B; Palmisano JN; Steinberg EG; Simkin I; Budson AE; Killiany R; O'Connor MK; Au R; Qiu WWQ; Goldstein LE; Kowall NW; Mez J; Stern RA; Alosco ML
    Neurobiol Aging; 2020 Oct; 94():60-70. PubMed ID: 32585491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
    Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X
    J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of plasma amyloid beta
    Verberk IMW; Thijssen E; Koelewijn J; Mauroo K; Vanbrabant J; de Wilde A; Zwan MD; Verfaillie SCJ; Ossenkoppele R; Barkhof F; van Berckel BNM; Scheltens P; van der Flier WM; Stoops E; Vanderstichele HM; Teunissen CE
    Alzheimers Res Ther; 2020 Sep; 12(1):118. PubMed ID: 32988409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV; Guyonnet S; Morley JE; Nguyen AD; Aggarwal G; Parini A; Li Y; Bateman RJ; Vellas B; de Souto Barreto P;
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1159-1168. PubMed ID: 35034116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia.
    Ma W; Zhang J; Xu J; Feng D; Wang X; Zhang F
    Dis Markers; 2020; 2020():6612871. PubMed ID: 33204362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.
    Baldacci F; Lista S; Manca ML; Chiesa PA; Cavedo E; Lemercier P; Zetterberg H; Blennow K; Habert MO; Potier MC; Dubois B; Vergallo A; Hampel H; ;
    Alzheimers Res Ther; 2020 Nov; 12(1):147. PubMed ID: 33183357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.